Home Article ResMed CEO sells 3,200 shares

ResMed CEO sells 3,200 shares

ResMed CEO sells 3,200 shares

Also Noted

Default Author Head Shot

By HME News Staff

Updated Thu July 17, 2014

SAN DIEGO - ResMed CEO Michael Farrell sold 3,200 shares of company stock on the open market July 15. The stock was sold at an average $49.22 for a total transaction of $157,504, according to news reports. Farrell now owns 106,655 shares of ResMed stock, worth about $5.2 million.

Comments

To comment on this post, please log in to your account or set up an account now.